Corporate
  • bioMérieux

    Created in 1963
  • Social networks

    1,684 310,295
  • Sectors

  • Location

    100 All. Louis Raymond, 69280 Marcy-l'Étoile, France

    Marcy-l'Étoile

    France

  • Engaged entities

    247
    181 48
  • Added in Motherbase

    18 Sep 2019, 4:49 p.m.
Description
  • Value proposition

    Pioneering Diagnostics

    Pioneering Diagnostics

    A world leader in the field of in vitro diagnostics for 60 years, bioMérieux is present in 45 countries and serves more than 160 countries with the support of a large network of distributors.

    In 2020, revenues reached €3.1 billion, with over 90% of sales outside of France.

    bioMérieux provides diagnostic solutions (systems, reagents, software, services) which determine the source of disease and contamination to improve patient health and ensure consumer safety.

    Its products are mainly used for diagnosing infectious diseases. They are also used for detecting microorganisms in agri-food, pharmaceutical and cosmetic products.

    bioMérieux is listed on the Euronext Paris stock market.

    Symbol: BIM – ISIN Code: FR0013280286
    Reuters: BIOX.PA/Bloomberg: BIM.FP


    in vitro diagnostics, infectious diseases, reagents, automated instruments, medical analysis, cosmetics, pharmaceutical, industries, healthcare associated infections, molecular biology, microbiology, immunoassays, antimicrobial stewardship, rapid diagnostics, food safety, veterinary diagnostics, blood bank, and sepsis

  • Original language

    Pioneering Diagnostics

    Pioneering Diagnostics

    A world leader in the field of in vitro diagnostics for 60 years, bioMérieux is present in 45 countries and serves more than 160 countries with the support of a large network of distributors.

    In 2020, revenues reached €3.1 billion, with over 90% of sales outside of France.

    bioMérieux provides diagnostic solutions (systems, reagents, software, services) which determine the source of disease and contamination to improve patient health and ensure consumer safety.

    Its products are mainly used for diagnosing infectious diseases. They are also used for detecting microorganisms in agri-food, pharmaceutical and cosmetic products.

    bioMérieux is listed on the Euronext Paris stock market.

    Symbol: BIM – ISIN Code: FR0013280286
    Reuters: BIOX.PA/Bloomberg: BIM.FP

Entity interactions BETA
Entity TypeTweets Articles
Molsid Molsid
biotech, deeptech, Biotechnology Research
Other

31 Oct 2021


EryPharm EryPharm
biotech, deeptech, Biotechnology Research
Other

31 Jan 2022


Aenitis Technologies Aenitis Technologies
biotech, deeptech, healthtech, Biotechnology Research
Other

31 Mar 2022


La Pirata Brewing La Pirata Brewing
foodtech, Food and Beverage Services
Other

30 Apr 2022


Dalibo Dalibo
IT Services, Software Development
Other

30 Jun 2022


Institut des Sciences Analytiques (ISA) - UMR 5280 Institut des Sciences Analytiques (ISA) - UMR 5280
Chemical Manufacturing
Other

8 Jul 2022


IFIS - Institut de Formation des Industries de Santé IFIS - Institut de Formation des Industries de Santé
edtech, Professional Training and Coaching
Other

22 Jul 2022


BioPharma Asia Magazine BioPharma Asia Magazine
Book and Periodical Publishing
Other

31 Jul 2022


Hospital Universitari Vall d'Hebron Hospital Universitari Vall d'Hebron
Hospitals and Health Care
Other

1 Aug 2022


Centers for Disease Control and Prevention Centers for Disease Control and Prevention
Government Administration
Other

1 Aug 2022


Radars
Loading...